Call for Abstract
Scientific Program
3rdInternational Conference on Vaccines & Vaccination, will be organized around the theme “Recent Innovations and Benchmark Practices in Vaccines & Vaccination”
Vaccines-2013 is comprised of 9 tracks and 57 sessions designed to offer comprehensive sessions that address current issues in Vaccines-2013.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Innate and acquired immunity, attenuated, conjugated, toxoid, and subunit vaccines
- Track 1-2Vaccine vectors
- Track 1-3Live attenuated, and killed vaccines
- Track 1-4Vaccine efficiency and effectiveness
- Track 2-1Response of B and T cells to the pathogens
- Track 2-2Immune responses to vaccines and immunomodulators
- Track 2-3Immunotherapy and chemo immunotherapy
- Track 2-4Nano and micro particles as adjuvants and delivery systems
- Track 2-5Macrophage model systems
- Track 2-6Targeted delivery approaches for vaccines
- Track 3-1Peptide vaccines, DNA vaccines, cancer vaccines
- Track 3-2Design and development of novel vaccines
- Track 3-3Recombinant DNA vaccine technology
- Track 3-4Polio vaccines, HIV vaccines
- Track 3-5Development of vaccine for human papilloma virus
- Track 3-6Carbohydrate / polysaccharide vaccine technology
- Track 4-1Vaccines against parasite infections
- Track 4-2Antiviral and antibacterial vaccines
- Track 4-3Biodefense vaccines: The filovirus experience
- Track 4-4Advance in novel pertussis vaccines
- Track 4-5Novel adjuvants
- Track 4-6Plant and animal based vaccines
- Track 4-7Biomarkers in vaccines
- Track 4-8Rotavirus vaccines
- Track 4-9Pneumococcal vaccines
- Track 4-10Emerging and re-emerging infectious disease vaccines
- Track 4-11Food safety vaccines, glyco-conjugate vaccines
- Track 5-1Techniques for the multi-product vaccine
- Track 5-2Robust and reproducible manufacturing techniques
- Track 5-3QA/QC strategies in vaccine development and production
- Track 5-4Technological improvements for downstream processing of vaccines
- Track 5-5Generation of vaccines using high-throughput micro bioreactors
- Track 5-6Mechanistic basic prophylactic and therapeutic vaccines
- Track 6-1Risk assessment and management of vaccine contamination
- Track 6-2Case studies for HIV and tropical diseases
- Track 6-3Personalized medicine development
- Track 6-4Current issues in vaccine communication, safety, and health policies
- Track 6-5Market trend and regulatory aspects of vaccine development and distribution
- Track 6-6Epidemiological studies and scientific assessment of vaccine adverse events
- Track 7-1Validation and optimization of treatment strategies for new targets
- Track 7-2Vaccine trials: Clinical testing, defining efficacy endpoints, and confirmatory studies
- Track 7-3Genetic predictors of immune response
- Track 7-4Long term vaccine therapy for clonal exhaustion
- Track 7-5Surveillance of vaccine preventable diseases
- Track 7-6Vaccines: Preclinical development
- Track 8-1Vaccine development strategies for neurodegenerative disorders
- Track 8-2New developments in veterinary vaccines
- Track 8-3Vaccine approaches to immunotherapy and clinical trials
- Track 8-4Nanotechnology in vaccine delivery
- Track 8-5Novel discoveries in allergen vaccines
- Track 8-6Advances in the delivery methods for transcutaneous immunization
- Track 9-1Vaccination in pregnancy and newborns
- Track 9-2Status and impact of childhood and adolescent immunizations
- Track 9-3Vaccination in adults and older individuals: New perspectives
- Track 9-4Travel immunizations and safety issues
- Track 9-5Immunization in immunocompromised patients
- Track 9-6Challenges in implementing immunization programs and improvement strategies